ABMT (Advanced BioMedical Technologies) Accounts Payable: $1.16 Mil (As of Jul. 2021)


What is Advanced BioMedical Technologies Accounts Payable?

Advanced BioMedical Technologies ABMT Accounts Payable is $1.16 Mil as of Jul. 2021.

Advanced BioMedical Technologies's Accounts Payable for the quarter that ended in Jul. 2021 was $1.16 Mil.

Advanced BioMedical Technologies's quarterly Accounts Payable stayed the same from Jan. 2021 ($0.00 Mil) to Apr. 2021 ($0.00 Mil) but then increased from Apr. 2021 ($0.00 Mil) to Jul. 2021 ($1.16 Mil).

Advanced BioMedical Technologies's annual Accounts Payable increased from Oct. 2018 ($0.00 Mil) to Oct. 2019 ($0.00 Mil) but then declined from Oct. 2019 ($0.00 Mil) to Oct. 2020 ($0.00 Mil).

Advanced BioMedical Technologies Accounts Payable Related Terms

Advanced BioMedical Technologies Accounts Payable Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Accounts Payable Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.16

Advanced BioMedical Technologies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.16 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Accounts Payable of $1.16 Mil as of Jul. 2021. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Accounts Payable too high?
Advanced BioMedical Technologies' current Accounts Payable is $1.16 Mil.
How does Advanced BioMedical Technologies' Accounts Payable compare to VYCO and ADMT?
Advanced BioMedical Technologies' Accounts Payable of $1.16 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Accounts Payable is $1.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Accounts Payable of $1.16 Mil. The current Accounts Payable is $1.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Accounts Payable is $1.16 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.